Publications

Publications

Filter Results: (1,253) Arrow Down
Filter Results: (1,253) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 56 of 1,253 Results →
  • 26 Jan 2009
  • Research & Ideas

Where is Home for the Global Firm?

you share these ideas? A: Of course, once you write something like this, you come to see many things through these lenses. As reported in the Financial Times in October, several UK firms including Shire Pharmaceuticals and WPP Group have... View Details
Keywords: by Martha Lagace
  • 01 Feb 2000
  • News

Executives Convene to Discuss Consumer-Driven Health Care

alumni event attracted more than sixty HBS graduates representing biotechnology, e-commerce, managed care, and pharmaceutical companies. The program featured briefings from HBS faculty members interested in issues related to health-care... View Details
  • 07 Oct 2014
  • First Look

First Look: October 7

(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for... View Details
Keywords: Sean Silverthorne
  • 02 Nov 2022
  • Blog Post

Climate Stories Episode #11: Mary Jo Veverka (HBS 1978): Fostering Actionable Climate Literacy

has had a storied business career. In the 1980s, she became the first female partner at Booz, Allen and helped build the consulting firm’s pharmaceutical practice. In the early 1990s, she was a deputy commissioner at the Food & Drug... View Details
  • 23 May 2000
  • Research & Ideas

Minding the Muse: The Impact of Downsizing on Corporate Creativity

pharmaceutical firms that rely on creativity," she says. "Today's fast-changing global markets place increased pressure on companies of every kind to continuously create new products, services, and competitive strategies if they... View Details
Keywords: by Peter K. Jacobs
  • 2022
  • Book

Les multinationales suisses dans l'arène politique (1942–1993) [Swiss Multinationals in the Political Arena (1942–1993)]

By: Sabine Pitteloud
En décembre 2020, les Suisses votaient sur l’initiative populaire « pour des multinationales responsables ». Cet épisode récent a rappelé que la régulation de l’activité des sociétés multinationales fait l’objet de luttes politiques, auxquelles participent les... View Details
Keywords: Multinational Enterprise; Multinational Companies; Multinational Corporations; Lobbying; Business ＆ Government Relations; Labor Relations; Relocation; Offshoring And Outsourcing; Corporate Regulation; Transnational Regulation; Multinational Firms and Management; Business and Government Relations; Governing Rules, Regulations, and Reforms; International Relations; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
Related
  • March 2017
  • Case

Cantel Medical

By: John R. Wells and Gabriel Ellsworth
Cantel Medical Corporation provided infection prevention and control products and services for patients, caregivers, and other healthcare providers. In 2016, Cantel generated sales of $665 million and net profits of $60 million, double the levels of five years earlier.... View Details
Keywords: Cantel; Charles Diker; Furniture Industry; Matrix Organization; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Units; Business Growth and Maturation; Business Organization; For-Profit Firms; Chemicals; Profit; Revenue; Geographic Scope; Multinational Firms and Management; Health; Health Care and Treatment; Business History; Business or Company Management; Goals and Objectives; Growth and Development Strategy; Organizational Structure; Problems and Challenges; Research and Development; Opportunities; Strategy; Adaptation; Business Strategy; Competitive Strategy; Corporate Strategy; Diversification; Expansion; Information Technology; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; New Jersey
Related
  • July 2017 (Revised July 2019)
  • Supplement

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)

By: Nori Gerardo Lietz and Ricardo Andrade
The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details
Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • July 2016 (Revised July 2019)
  • Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Related
  • April 2016 (Revised July 2019)
  • Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Related
  • August 2003
  • Teaching Note

Pharmacyclics: Financing Research and Development (TN)

By: Malcolm P. Baker and Richard S. Ruback
Teaching Note for (9-201-056). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 12 Jan 2016
  • First Look

January 12, 2016

November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
  • Web

Winners & Success Stories | New Venture Competition

make considerable achievement gains while building their self-confidence. The Company collaborates with parents, schools, community organizations, and local educators to implement programs that will help students succeed in school, and ultimately in life. Potentia... View Details
  • 06 Aug 2001
  • Research & Ideas

Go Global—or No? Can You Make the Case?

Remember, we don't yet have the capability to serve the chemical and pharmaceutical industries here. There are still only 38 of us, and I estimate that building the support infrastructure we need just for domestic expansion could cost as... View Details
Keywords: by Walter Kuemmerle
  • 23 Oct 2019
  • News

After the Storm

class. When I started at Johnson & Johnson right after business school, I remember being the only African American female pharmaceutical sales rep in the mid-Atlantic region at that time. It’s a sad reality, but that is also why I get so... View Details
Keywords: Elementary and Secondary Schools; Educational Services
  • 04 Sep 2018
  • First Look

New Research and Ideas, September 4, 2018

It subsequently became much more arduous for pharmaceutical firms to bring new drugs to market. Some critics therefore argued that the new regulations were actually detrimental, as they prevented or delayed good drugs from coming to... View Details
Keywords: Dina Gerdeman
  • 24 Jan 2012
  • First Look

First Look: Jan. 24

This chapter proposes a new lens to understand corruption, using internal records collected from firms that pay bribes. We examine widespread corruption in three industries in an Asian developing country: procurement, pharmaceutical... View Details
Keywords: Sean Silverthorne
  • November 2006
  • Case

Competitive Headaches (A): The Analgesic Wars

By: Dennis A. Yao
Addresses the problem of competing with a me-too consumer product. Focuses on Bristol-Meyers' 1975 strategy for introducing a competitor to Tylenol in the analgesic market. View Details
Keywords: Market Entry and Exit; Competition; Competitive Advantage; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • November 1999
  • Teaching Note

drugstore.com TN

By: Richard L. Nolan
Teaching Note for (9-300-036). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 22 Apr 2014
  • First Look

First Look: April 22

constraints. Download working paper: https://www.hbs.edu/faculty/Pages/download.aspx?name=14-097.pdf The Organizational and Geographic Drivers of Absorptive Capacity: An Empirical Analysis of Pharmaceutical R&D Laboratories By:... View Details
Keywords: Sean Silverthorne